Abstract | OBJECTIVES: Literature is lacking regarding the utilization of first-generation cephalosporins for the treatment of acute pyelonephritis. The aim of this study was to determine whether cefazolin is non-inferior to ceftriaxone for the empirical treatment of acute pyelonephritis in hospitalized patients. The primary outcome included a composite of symptomatic resolution plus either defervescence at 72 h or normalization of serum white blood cell count at 72 h (non-inferiority margin 15%). Secondary outcomes included length of stay and 30 day readmission. A subgroup analysis of the composite outcome was also conducted for imaging-confirmed pyelonephritis. METHODS: This was a retrospective, non-inferiority, multicentre, cohort study comparing cefazolin versus ceftriaxone for the empirical treatment of acute pyelonephritis in hospitalized patients. RESULTS: Overall, 184 patients received one of the two treatments between July 2009 and March 2015. The composite outcome was achieved in 80/92 (87.0%) in the cefazolin group versus 79/92 (85.9%) in the ceftriaxone group (absolute difference 1.1%, 95% CI -11.1% to 8.9%, Pā=ā0.83), meeting the pre-defined criteria for non-inferiority. The composite outcome for patients with imaging-confirmed pyelonephritis was achieved in 46/56 (82.1%) versus 42/50 (84.0%) for the cefazolin group and the ceftriaxone group, respectively (absolute difference 1.9%, 95% CI -12.8% to 16.5%, Pā=ā0.80). Additionally, there were no statistically significant differences in length of stay or 30 day readmission for cystitis or pyelonephritis. CONCLUSIONS:
|
Authors | Athena L V Hobbs, Katherine M Shea, Mitchell J Daley, R Gordon Huth, Theresa C Jaso, Jack Bissett, Vagish Hemmige |
Journal | The Journal of antimicrobial chemotherapy
(J Antimicrob Chemother)
Vol. 71
Issue 6
Pg. 1665-71
(06 2016)
ISSN: 1460-2091 [Electronic] England |
PMID | 26983859
(Publication Type: Comparative Study, Journal Article, Multicenter Study)
|
Copyright | © The Author 2016. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: [email protected]. |
Chemical References |
- Anti-Bacterial Agents
- Cephalosporins
- Ceftriaxone
- Cefazolin
|
Topics |
- Acute Disease
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Anti-Bacterial Agents
(therapeutic use)
- Cefazolin
(therapeutic use)
- Ceftriaxone
(therapeutic use)
- Cephalosporins
(therapeutic use)
- Cohort Studies
- Empirical Research
- Escherichia coli
(isolation & purification)
- Escherichia coli Infections
(drug therapy, urine)
- Female
- Hospitalization
- Humans
- Length of Stay
- Leukocyte Count
- Male
- Middle Aged
- Patient Readmission
- Pyelonephritis
(blood, diagnostic imaging, drug therapy, microbiology)
- Retrospective Studies
- Young Adult
|